Scailyte

Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery

placeLucerne, Lucerne, Switzerland calendar_todayFounded 2017 groups28 employees language scailyte.com

Social engagement

Social engagement: 6.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Venturelab, Swisscom Ventures, Swisscom, Mirabaud.

Investor typeCountShare
Venture capital333%
Accelerator & incubator333%
Bank & private debt111%
Other / undisclosed222%

Recent activity

6 May 2026
Milestone
regulatory
19 Mar 2026
Event
Future Health Basel
11 Mar 2026
Product launch
IBD Flagship program
Coming soon